Pharmaceutical company in the
Canton of Schwyz
68 companies in Pharmaceutical company based in the Canton of Schwyz — name and year of registration from the commercial register.
50 of 68 companies
Schwabe Pharma AG
Since 1992 · 51–100 empl.
Schwabe Pharma AG manufactures and distributes homeopathic medicines and Dr. Schüssler biochemical mineral salts under the OMIDA brand. Its range includes single and combination remedies in various dosage forms.
Octapharma AG
Since 1999 · 101–500 empl.
Octapharma AG is a global healthcare company that develops and manufactures medicines based on human proteins. Its therapeutic areas include haemophilia, immunology and critical care.
Swyssi PMFS AG
Since 2000 · 11–20 empl.
Swyssi PMFS AG develops and manufactures complex generic medicines and works on extending the life cycle of established prescription pharmaceuticals. Its activities include product development, market entry and brand building, with products in areas such as cardiovascular disease, diabetes, central nervous system disorders, respiratory conditions and antibiotics.
adastra AG
Since 2004 · 1–10 empl.
adastra AG is a floorball club with men’s and youth teams. The club runs competitive and development programs, supports junior players, and provides services for members, volunteers, and sponsors.
Shield TX (Switzerland) AG
Since 2009 · 51–100 empl.
Shield TX (Switzerland) AG is a subsidiary of the Shield Therapeutics group, a commercial-stage pharmaceutical company focused on medicines for iron deficiency. The group’s portfolio includes ferric maltol, an oral medicine for the treatment of iron deficiency.
PhytoNet AG
Since 2009 · 51–100 empl.
PhytoNet AG distributes ingredients for health and nutrition products and develops and manufactures finished formulations for human and animal healthcare. It also provides pharmaceutical product development and contract manufacturing services.
EffRx Pharmaceuticals SA
Since 2009 · 11–20 empl.
EffRx Pharmaceuticals SA is a pharmaceutical company focused on the late-stage development and commercialization of medicines for rare endocrine and metabolic disorders and musculoskeletal diseases. It focuses on the Swiss and European markets and commercializes products including Binosto for the treatment of osteoporosis.
Benemedo GmbH
Since 2010 · 11–20 empl.
Benemedo GmbH provides brands in dermatology, dermocosmetics and healthcare. The company develops its own product lines and offers pharmaceutical and cosmetics partners sales, marketing and collaboration services.
Swiss-Canna Group AG
Since 2012 · 1–10 empl.
Swiss-Canna Group AG is a holding and investment company for businesses in women’s and menstrual care. The group develops and markets products including CBD tampons, sanitary pads and pantyliners, and is involved in production, logistics, product development, marketing and sales.
HISTIDE AG
Since 2014 · 21–50 empl.
HISTIDE AG is a biotechnology company developing a platform of extracellular therapeutic agents called Cell Recoding Molecules. Its research and development pipeline covers oncology, metabolic and neurological disorders, rare diseases, and medical devices for tissue regeneration.
Hempcare GmbH
Since 2018 · 11–20 empl.
Hempcare GmbH cultivates hemp, processes it and distributes Swiss CBD products. Its range includes CBD flowers, hemp extracts and oils, cuttings, and CBD flowers and extracts as raw materials for pharmaceutical processing and the food industry.
Somagenetix AG
Since 2019 · 11–20 empl.
Somagenetix AG is a biotechnology company developing gene therapies for genetic disorders affecting phagocytes. Its platform uses lentiviral vectors and blood stem cells; its lead candidate, SGX-001, is being studied in clinical trials for chronic granulomatous disease.
MediCrops AG
Since 2019 · 51–100 empl.
MediCrops AG develops and operates digital and pharmaceutical infrastructure for connected healthcare. Its care systems combine medical expertise, digital platforms and operations approved under regulatory requirements.
Salus Schweiz AG
Since 2020 · 11–20 empl.
Salus Schweiz AG markets and distributes nature-based products for health and wellbeing. Its range includes food supplements, teas, tonics, elixirs, fresh plant juices and beauty and care products from the Salus, Floradix and Schoenenberger brands.
IDEOGEN AG
Since 2013 · 21–50 empl.4.0(4)
IDEOGEN AG operates in the pharmaceutical sector, facilitating access to specialty medicines for medical needs with limited treatment options. Its activities include the commercialization and distribution of licensed and unlicensed medicines, special access programs, and research and development.
DiNAQOR AG
Since 2024 · 21–50 empl.
DiNAQOR AG is a biotechnology company builder that develops platform technologies and launches focused companies in tissue science, precision medicine and genetic therapies. Its portfolio includes entities such as DiNATEQ, DiNAMIQS, DiNABiOS and DAiNA; the group provides access to GMP‑compliant viral vector manufacturing and advances precision gene‑therapy programs for cardiomyopathies, heart failure and polycystic kidney disease.
MABEWO PHYTOPHARM AG
Since 2020 · 1–10 empl.4.1(9)
MABEWO PHYTOPHARM AG develops and supplies technologies and services for producing plant-based medicines and phytopharmaceuticals. Its offering includes modular, scalable facilities and support with planning, building and commissioning production processes and technical equipment.
Delta4 AG
Since 2023 · 11–20 empl.
Delta4 AG is a TechBio company applying AI and systems biology to drug discovery and the expansion of indications for existing medicines. Its Hyper-C platform supports activities including drug target and biomarker identification, and the prediction of drug effects.
pharma services Oehler GmbH
Since 2006 · 11–20 empl.5.0(2)
pharma services Oehler GmbH advises and supports pharmaceutical companies in quality assurance, regulatory affairs and pharmacovigilance. Its services also cover food, cosmetic products and medical devices.
Path Pharma GmbH
Since 2023 · 11–20 empl.
Path Pharma GmbH licenses and commercializes pharmaceutical products, with a focus on niche products. Its activities include medicines for rare diseases, oncology and haematology, as well as market access, medical support and patient support services.
Mera Pharma GmbH
Since 2012 · 11–20 empl.5.0(3)
Mera Pharma GmbH is a pharmaceutical company with a portfolio of dietary supplements, medical devices and cosmetics. It develops its product range, including nutritional products for a variety of needs and medical devices.
IDEOGEN GROUP GmbH
Since 2021 · 21–50 empl.4.0(4)
IDEOGEN GROUP GmbH is a pharmaceutical group that facilitates access to specialty medicines for unmet medical needs. Its activities include commercialization, distribution and managed access to licensed and unlicensed medicines, as well as research, development and pharmaceutical investment.
Saiba X AG
Since 2024 · 1–10 empl.
Saiba X AG develops vaccines and virus-like particle technologies for use against chronic and infectious diseases. The company also provides consulting, licensing and development services for vaccine projects.
Cantreat AG
Since 2023 · 11–20 empl.4.0(1)
Cantreat AG develops, manufactures and distributes medical devices for cancer treatment. Its method uses magnetically controllable nanoparticles carrying approved cytostatic drugs, positioned in tumour tissue by an external magnetic system.
CellShield AG
Since 2019 · 1–10 empl.
CellShield AG invests financial resources and supports ventures capable of generating returns, with the aim of securing proceeds.
TACHRIS AG
Since 2008 · 1–10 empl.
Pharmacon AG
Since 2013 · 1–10 empl.
Pharmacon AG is a company whose website provides contact details but no information about products, services, or business activities. The site only shows the company name, address, phone number, and email address.
Focus Health AG
Since 1965 · 1–10 empl.
Matterhorn AG, Pharmazeutica
Since 1986 · 1–10 empl.
NCC Nutrition Care Company AG
Since 2000 · 1–10 empl.
athenstaedt AG
Since 2001 · 1–10 empl.
EuroPharma GmbH
Since 2001 · 1–10 empl.
Sedapharm AG
Since 2004 · 1–10 empl.
Phoenux AG
Since 2005 · 1–10 empl.
GENERA PHARMA AG
Since 2005 · 1–10 empl.
Dicon AG
Since 2006 · 1–10 empl.
Alembic Global Holding SA
Since 2007 · 1–10 empl.
Castiglione Medica GmbH
Since 2009 · 1–10 empl.
Mind-NRG Sàrl
Since 2010 · 1–10 empl.
HealVax GmbH
Since 2011 · 1–10 empl.
Santis Pharma AG
Since 2011 · 1–10 empl.
Burgerstein Apotheke AG
Since 2014 · 1–10 empl.
Shiva Pharmachem SA
Since 2014 · 1–10 empl.
Pharmafox Therapeutics AG
Since 2014 · 1–10 empl.
Medicalsanomed AG
Since 2015 · 1–10 empl.
Swiss Nutri GmbH
Since 2016 · 1–10 empl.
Pharmaprint GmbH
Since 2018 · 1–10 empl.
New Horizon Global GmbH
Since 2018 · 1–10 empl.
GxP-Agentur GmbH
Since 2019 · 1–10 empl.
photokgsessions ag
Since 2019 · 1–10 empl.
Pharmaceutical company in the Canton of Schwyz
Pharmaceutical company in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of November 7, 2026
Pharmaceutical company in other places
By canton